Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul-Aug;9(4):161-75.
doi: 10.1007/s11307-007-0088-1.

In vitro imaging techniques in neurodegenerative diseases

Affiliations
Review

In vitro imaging techniques in neurodegenerative diseases

Bengt Långström et al. Mol Imaging Biol. 2007 Jul-Aug.

Abstract

Neurodegeneration induces various changes in the brain, changes that may be investigated using neuroimaging techniques. The in vivo techniques are useful for the visualization of major changes, and the progressing abnormalities may also be followed longitudinally. However, to study and quantify minor abnormalities, neuroimaging of postmortem brain tissue is used. These in vitro methods are complementary to the in vivo techniques and contribute to the knowledge of pathophysiology and etiology of the neurodegenerative diseases. In vitro radioligand autoradiography has given great insight in the involvement of different neuronal receptor systems in these diseases. Data on the dopamine and cholinergic systems in neurodegeneration are discussed in this review. Also, the amyloid plaques are studied using in vitro radioligand autoradiography. Using one of the newer methods, imaging matrix-assisted laser desorption ionization mass spectrometry, the distribution of a large number of peptides and proteins may be detected in vitro on brain cryosections. In this overview, we describe in vitro imaging techniques in the neurodegenerative diseases as a complement to in vivo positron emission tomography and single photon emission computed tomography imaging.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Neurosci. 2005 Nov 23;25(47):10857-62 - PubMed
    1. Eur J Clin Pharmacol. 2003 Sep;59(5-6):357-66 - PubMed
    1. J Neurosci Methods. 1991 Jan;36(1):53-61 - PubMed
    1. Alzheimer Dis Assoc Disord. 1987;1(1):3-8 - PubMed
    1. Neurobiol Aging. 2003 Dec;24(8):1029-46 - PubMed

LinkOut - more resources